Investment Bank for the Healthcare Sector
With insights and relationships throughout the healthcare ecosystem, our team excels at securing ideal partners to create value for our clients.
>25
global healthcare professionals
60+
transactions since 2015
>$6 billion
value of transactions advised
Providing Quality Outcomes for Healthcare Clients
Healthcare is one of the most dynamic and complex areas in the global economy. Healthcare leaders who want to capitalize on rapid changes in science, regulation, technology and therapeutics benefit from the expertise of investment banking advisors with relevant experience and a keen focus on their unique goals. Our passion for healthcare and our focus on creating shareholder value for our clients has made us one of the fastest growing healthcare M&A practices in the world.
Sector Focus
Provider Services
Home Healthcare
Physician Services
Outpatient Services
Pharmacy Services
Pharmaceutical & Lab Services
Contract Research Organizations
Analytical Lab Services
Clinical Lab Services
Contract Manufacturing
Process Outsourcing
Hospital Outsourcing
Revenue Cycle Management
Employer Health Services
Healthcare IT
Medical Devices & Outsourcing
Devices & Equipment
Products & Supplies
Medical Components
Contract Design / Manufacturing
Life Sciences
Diagnostic Instruments
Research Equipment
Lab Supplies
Consumables & Kits
Managed Care
Health Plans
Third-Party Administration
Benefits Management
Payor Outsourced Services
Perspectives & Publications

Lincoln International’s Global Healthcare Group Announces Strong Results in 2022
Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance… Read More

Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence
Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.

2022 Global Results
In 2022, Lincoln International continued to design and deliver meaningful solutions and outcomes for clients around the world. Our shared ambition for results achieved through collaboration, thoughtfulness and tailored approaches… Read More

Lincoln International Announces Managing Director Promotions 2022
Lincoln International, a global investment banking advisory firm, is pleased to announce the promotion of six Directors to Managing Director (MD), effective January 1, 2023. “Each of these individuals contributes… Read More
Lincoln’s expertise in healthcare services and with private companies, combined with their process execution capabilities, proved to be invaluable. At all times the Lincoln team acted as a trusted advisor and truly understood the needs of an owner-entrepreneur."
Recent Transactions In Healthcare
Meet our Senior Team with Healthcare Expertise

I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | Management Board Member
FrankfurtMeet our Global Heads

I am enthusiastic about creating sustainable growth and the highest value for our clients, and strive to leave a positive footprint beyond any successful M&A transaction.
Friedrich Bieselt
Managing Director | Management Board Member
Frankfurt
I enjoy leading clients and realizing their objectives, while structuring solutions to issues that are both intriguing and challenging.
Øyvind Bjordal
Managing Director | Head of Switzerland
Zurich
My goal is to inspire and motivate our people to make a true impact with their clients, their colleagues and their communities.
Robert Brown
CEO | Managing Director | GP-Director
Chicago
Building long-term relationships is key for me personally – I want to be the advisor of trust for my clients.
Dr. Michael Drill
Managing Director | CEO Germany | Chairman of the Management Board
Frankfurt